Vox Biomedical LLC
Bedford, MA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 4 Preston Ct #102, Bedford, MA 01730, USA
- Website
- voxbiomedical.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Brigham & Womens Hospital Inc. | R01AI175040 | $290,563 | |
| Brigham & Womens Hospital Inc. | U01TR004072 | $902,886 |
Similar vendors
About the company
Vox Biomedical LLC is a for-profit limited liability company located in Bedford, Massachusetts, registered in SAM.gov since March 2019, with a focus on developing advanced technological solutions for breath and volatile organic compound (VOC) analysis. The company specializes in developing innovative scientific instrumentation and research methodologies targeting drug detection, disease identification, and analytical measurement technologies, with a particular emphasis on creating sophisticated microanalysis systems for breath and skin-based molecular detection.
Through its federal contract work, Vox Biomedical has engaged in Small Business Innovation Research (SBIR) projects, specifically a $539,328 contract with the U.S. Department of Transportation to develop technology for detecting tetrahydrocannabinol (THC) use in drivers via breath analysis. The contract was set aside for total small businesses and focused on Phase II research efforts to advance detection methodologies. While the company has not been identified as having multiple prime federal contract awards, its work demonstrates a commitment to developing cutting-edge technological solutions for government agencies with specific scientific research needs.
Regarding federal grant awards, Vox Biomedical has received significant funding from multiple National Institutes of Health agencies, including the National Institute on Drug Abuse and the National Institute of General Medical Sciences. These grants have supported research into advanced breath aerosol capture techniques, machine learning-based molecular identification libraries, and innovative microanalysis instrumentation for detecting drugs and diseases. The company has also been involved in sub-grant work with Brigham & Women's Hospital, developing modifications to their gas chromatography and differential mobility spectrometry (GC/DMS) microanalyzer instrument for applications including respiratory syndrome differentiation, skin VOC detection, and chronic disease identification. These grant-funded projects demonstrate the company's sophisticated approach to developing portable, point-of-measurement analytical technologies with broad potential applications in medical diagnostics and screening.
Quick answers
Is Vox Biomedical LLC registered in SAM.gov?
Yes. Vox Biomedical LLC's SAM.gov registration is active through July 27, 2027.
What is Vox Biomedical LLC's CAGE code?
Vox Biomedical LLC's CAGE code is 8BCS2, and its Unique Entity ID (UEI) is FNQYUK4GTB29.
What is Vox Biomedical LLC's most recent federal award?
Vox Biomedical LLC's most recent federal grant award is Breath aerosol capture by electric field concentration (R43DA060905), from National Institute on Drug Abuse (NIH), on August 15, 2024.
On GovTribe
See Vox Biomedical LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors